Genevieve Brunette

BMO Capital Markets Corp. (Canada) (BMO Capital Markets-Canada) is the Canadian brokerage arm of BMO Capital Markets Corp., a full-service financial services provider in the US. The firm was founded in 1817 and is a subsidiary of BMO Asset Management, Inc., which is owned by Bank of Montreal (NYSE, TSX: BMO) in Canada. Headquartered in Toronto, BMO Capital Markets-Canada provides full-service, institutional brokerage services to corporate, institutional and government clients around the world.

iSeva Pvt Ltd. provides outsourcing services to the mortgage and high technology industries. It provides end to end outsourcing services, telesales, verification, application processing, and technical support services. The company was founded in November, 1999 and is headquartered in Santa Clara, CA.

Part of Royal Bank of Canada, Ernst & Young Orenda Corporate Finance, Inc. provides investment banking services.

Fonds de Solidarité FTQ (Fonds Régional de Solidarité FTQ) is a private equity firm founded in June 1983. The firm is headquartered in Montréal, Quebec.

iNovia Capital, Inc., formerly MSBi Capital, is a venture capital firm founded in 2001 by Shawn Abbott. The firm is headquarters in Montreal Canada.

EnerTech Capital Partners (EnerTech Capital) is a venture capital firm founded in 1996 by Scott Ungerer. The firm is headquartered in Ambler, Pennsylvania.

Réseau Capital operates as a venture capital and private equity association. It promotes private equity industry in Quebec through training, information and promotion, networking, and representation. The company was founded by Jean-Pierre Chartrand in 1989 and is headquartered in Montréal, Canada.

Iaculor Injection, Inc. develops needle free medical devices. It engages in the development and commercialization of needle-free medical devices for injecting drugs and vaccines. The company was founded by Martin Brouillette and is headquartered in Sherbrooke, Canada.

Mimetogen Pharmaceuticals, Inc. develops peptidomimetic small molecule drugs against glaucoma and cancer. Its product mimic the effects of neurotrophin proteins that help to maintain the health and growth of cells and tissues found in the eye. Mimetogen provides tyrosine kinase agonists that prevent neuronal death; small molecule tyrosine kinase receptor agonists, which stimulates mucin secretion from conunctival goblet cells; and small molecule neurotrophin mimetics that rescues retinal pigment epithelial cells from oxidative stress-induced apoptosis. The company was founded by Garth Cumberlidge and H. Uri Saragovi in 2005 and is headquartered in Montreal, Canada.

Grand Challenges Canada provides support services for healthcare. It specializes in global health, innovation, global mental health, international development, impact investing, maternal, newborn and child health, and research and development. The company was founded in May 2010 is headquartered in Toronto, Canada.

Insitut de Recherche en Immunologie et en Cancérologie develops and discovers treatment and therapies for cancers. It also engages in anticancer drug discovery chain. The company was founded in 2003 and is headquartered in Montréal, Canada.

Northern Biologics Inc. operates as an early-stage biologics company. It develops a portfolio of antibody-based therapeutics for oncology and fibrosis. The company was founded by Jason Moffat, Rob Rottapel, Benjamin G. Neel, Sachdev Sidhu, Brad Wouters, and Stefan Larson in June 2014 and is headquartered in Toronto, Canada.

InnoCité MTL operates as a startup firm that addresses the needs of city dwellers. It focuses on catalog of training and practical workshops, mentors ecosystem including entrepreneurs, corporate executives as well as municipal representatives and individual coaching throughout the program for selected startups. The company was founded in 2015 and is headquartered in Montreal, Canada.

35Pharma, Inc. designs and develops biologics for diseases of high unmet medical need. The CEO of the Canadian company is Ilia A. Tikhomirov.